CCEL Q4 2023 Earnings — Cryo-Cell International, Inc. Revenue & Financial Results | Market Cap Arena

CCELCryo-Cell International, Inc.

$26M

Q4 2023 Earnings

Healthcare Medical - Care Facilities

Income Statement

Revenue

$8M+1.5% YoY

Gross Profit

$6M73.6% margin

Operating Income

-$16M-205.4% margin

Net Income

-$11M-142.1% margin

EPS (Diluted)

$-1.34

QoQ Revenue Growth

+0.1%

Cash Flow

Operating Cash Flow

$3M

Free Cash Flow

$1M

Stock-Based Comp.

$174,949

Balance Sheet

Total Assets

$61M

Total Liabilities

$72M

Stockholders' Equity

-$11M

Cash & Equivalents

$406,067

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$8M	+1.5%
Gross Profit	$6M	$6M	+3.1%
Operating Income	-$16M	$581,677	-2880.9%
Net Income	-$11M	$837,822	-1435.6%

Revenue Segments

Processing And Storage Fees

$8M99%

Public Banking

$82,2521%

Product

$4,5360%